BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38162051)

  • 1. [Characteristics of Inflammatory Markers in Diabetic Foot Patients and Their Relationship With Prognosis of Diabetic Foot Ulcers].
    Wu J; Raju B; Zha P; Gong H; Ren Y; Li Z; Chen L; Liu G; Chen D; Wang C; Ran X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1233-1238. PubMed ID: 38162051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative Analysis of Clinical Efficacy of Negative Pressure Wound Therapy Plus Lavage System in the Treatment of Wagner Grade 3-5 Diabetic Foot Ulcers Combined with Infection].
    Chen Y; Li YX; Liu X; Yin SJ; Ouyang XY; Zhang H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 53(6):981-987. PubMed ID: 36443038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of inflammatory markers in diagnosing infected diabetic foot ulcers and diabetic foot osteomyelitis: Systematic review and meta-analysis.
    Sharma H; Sharma S; Krishnan A; Yuan D; Vangaveti VN; Malabu UH; Haleagrahara N
    PLoS One; 2022; 17(4):e0267412. PubMed ID: 35476639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of procalcitonin, erythrocyte sedimentation rate (ESR), quantitative C-reactive protein (CRP) and clinical findings associated with osteomyelitis in patients with diabetic foot.
    Soleimani Z; Amighi F; Vakili Z; Momen-Heravi M; Moravveji SA
    Hum Antibodies; 2021; 29(2):115-121. PubMed ID: 33749641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of procalcitonin as a marker of diabetic foot ulcer infection.
    Massara M; De Caridi G; Serra R; Barillà D; Cutrupi A; Volpe A; Cutrupi F; Alberti A; Volpe P
    Int Wound J; 2017 Feb; 14(1):31-34. PubMed ID: 26511007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Value of Soluble CD14, Interleukin-6 and Procalcitonin For Lower Extremity Amputation in People with Diabetes with Foot Ulcers: A Pilot Study.
    Karakas A; Arslan E; Cakmak T; Aydin I; Akgul EO; Demirbas S
    Pak J Med Sci; 2014 May; 30(3):578-82. PubMed ID: 24948983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of inflammatory markers to diagnose and monitor diabetic foot osteomyelitis.
    Van Asten SA; Nichols A; La Fontaine J; Bhavan K; Peters EJ; Lavery LA
    Int Wound J; 2017 Feb; 14(1):40-45. PubMed ID: 26634954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Characteristics of Diabetic Patients with Initial and Recurrent Foot Ulcers].
    Gong HP; Ren Y; Zha PP; Li Y; Raju B; Gao Y; Chen DW; Ran XW; Wang C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 53(6):969-975. PubMed ID: 36443036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration.
    Tabur S; Eren MA; Çelik Y; Dağ OF; Sabuncu T; Sayiner ZA; Savas E
    Wien Klin Wochenschr; 2015 Jan; 127(1-2):45-50. PubMed ID: 25398288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Hyperbaric Oxygen Therapy in Diabetic Foot Ulcers Based on Wagner Classification.
    Erdoğan A; Düzgün AP; Erdoğan K; Özkan MB; Coşkun F
    J Foot Ankle Surg; 2018; 57(6):1115-1119. PubMed ID: 30368425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can procalcitonin be an accurate diagnostic marker for the classification of diabetic foot ulcers?
    Jonaidi Jafari N; Safaee Firouzabadi M; Izadi M; Safaee Firouzabadi MS; Saburi A
    Int J Endocrinol Metab; 2014 Jan; 12(1):e13376. PubMed ID: 24696696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the healing potential of short-term ozone therapy for the treatment of diabetic foot ulcers.
    Sun H; Heng H; Liu X; Geng H; Liang J
    Front Endocrinol (Lausanne); 2023; 14():1304034. PubMed ID: 38292773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and risk factors of diabetic foot ulcers with PAD.
    Tao GL; Zheng LS; Wang ZY; Xu YP; Zhong XG; Wang H; Zhang XS
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(23):11412-11420. PubMed ID: 38095389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study.
    Jeandrot A; Richard JL; Combescure C; Jourdan N; Finge S; Rodier M; Corbeau P; Sotto A; Lavigne JP
    Diabetologia; 2008 Feb; 51(2):347-52. PubMed ID: 17934713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is ischaemia-modified albumin a biomarker in wagner classification in diabetic foot ulcers?
    Ozkan S; Adanas C; Alp HH
    Int J Clin Pract; 2021 Dec; 75(12):e14830. PubMed ID: 34510669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Serum Levels of Lp-PLA2 and IL-18 are Associated with Progression of Diabetic Foot Ulcers.
    Chen T; Yu J; Wang J; Chang Q; Qian C
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical Characteristics and Prognosis of Diabetic Foot Ulcers Patients of Different Renal Function Statuses].
    Chen DW; Gong HP; Ren Y; Li Y; Chen LH; Tang WW; Gao Y; Wang C; Ran XW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):165-170. PubMed ID: 36647661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of wound calprotectin and other inflammatory biomarkers aid in deciding which patients with a diabetic foot ulcer need antibiotic therapy (INDUCE study).
    Ingram JR; Cawley S; Coulman E; Gregory C; Thomas-Jones E; Pickles T; Cannings-John R; Francis NA; Harding K; Hood K; Piguet V
    Diabet Med; 2018 Feb; 35(2):255-261. PubMed ID: 28734103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Procalcitonin more superior to hs-CRP in the diagnosis of infection in diabetic foot ulcer?
    Zakariah NA; Bajuri MY; Hassan R; Ismail Z; Md Mansor M; Othman H; Nasuruddin DN
    Malays J Pathol; 2020 Apr; 42(1):77-84. PubMed ID: 32342934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Evaluation of the Diagnostic Value of Procalcitonin and hsCRP for the Presence of Mild-to-Moderate Diabetic Foot Infections.
    Todorova AS; Dimova RB; Chakarova NY; Serdarova MS; Grozeva GG; Georgiev GK; Tankova TI
    Int J Low Extrem Wounds; 2023 Jun; 22(2):353-359. PubMed ID: 33909506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.